Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Kathleen Moore, John K. Chan, Angeles Alvarez Secord, Manish R. Patel, Timothy Callahan, Wei Guo, Zhi-Yi Zhang

ABSTRACT

PURPOSE: Anticancer drugs may cause cardiovascular toxicities, including QT interval prolongation. Niraparib, a potent and selective once-daily oral poly (ADP-ribose) polymerase inhibitor, is approved as a maintenance therapy in platinum-sensitive recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer (EOC). Here, we present the effects of niraparib on cardiac repolarization, and the correlation between changes in baseline QT interval corrected by Fridericia's formula (ΔQTcF) and niraparib plasma concentrations. METHODS: Patients with EOC from the NOVA study (subset of n = 15), the food effect NOVA substudy (n = 17), and a QTc substudy (n = 26) underwent intensive electrocardiographic (ECG) monitoring that included triplicate ECG testing on Day 1 at baseline (predose) and at 1, 1.5, 2, 3, 4, 6, and 8 h postdose concurrent with time-matched blood sampling for determination of niraparib plasma concentrations. All patients received once-daily 300-mg niraparib until disease progression or toxicity. RESULTS: Across the 3 substudies, the upper limit of the two-sided 90% confidence interval (CI) of ΔQTcF was ≤ 10 ms at every postdose timepoint, with a maximum upper limit of 4.3 ms, which indicates no clinically meaningful effect on QTc prolongation. No statistically significant relationship between ΔQTcF and niraparib plasma concentration was observed (estimated slope: 0.0049; 95% CI: - 0.0020, 0.0117; P = 0.164). There were no clinically relevant changes in other ECG parameters that could be attributable to niraparib. CONCLUSION: Niraparib administration at the recommended daily dose of 300 mg for EOC is not associated with clinically relevant alteration of ECGs, including QTc prolongation. More... »

PAGES

717-726

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-019-03774-w

DOI

http://dx.doi.org/10.1007/s00280-019-03774-w

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111636836

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30680521


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Sarah Cannon", 
          "id": "https://www.grid.ac/institutes/grid.419513.b", 
          "name": [
            "Stephenson Cancer Center, University of Oklahoma HSC, 800 NE 10th St #2500, 73104, Oklahoma City, OK, USA", 
            "Sarah Cannon Research Institute, Nashville, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moore", 
        "givenName": "Kathleen", 
        "id": "sg:person.014355765517.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014355765517.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "California Pacific Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.17866.3e", 
          "name": [
            "Palo Alto Medical Foundation, California Pacific Medical Center, Sutter Health Sutter West Bay, San Francisco, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chan", 
        "givenName": "John K.", 
        "id": "sg:person.013072753512.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013072753512.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Cancer Institute, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Secord", 
        "givenName": "Angeles Alvarez", 
        "id": "sg:person.01153251200.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153251200.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Florida Cancer Specialists & Research Institute", 
          "id": "https://www.grid.ac/institutes/grid.488785.e", 
          "name": [
            "Sarah Cannon Research Institute, Nashville, TN, USA", 
            "Florida Cancer Specialists and Research Institute, Sarasota, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Patel", 
        "givenName": "Manish R.", 
        "id": "sg:person.01063520446.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063520446.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "BioTel Research, Rockville, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Callahan", 
        "givenName": "Timothy", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tesaro (United States)", 
          "id": "https://www.grid.ac/institutes/grid.476732.3", 
          "name": [
            "TESARO, Inc, Waltham, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guo", 
        "givenName": "Wei", 
        "id": "sg:person.013451310020.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013451310020.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tesaro (United States)", 
          "id": "https://www.grid.ac/institutes/grid.476732.3", 
          "name": [
            "TESARO, Inc, Waltham, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "Zhi-Yi", 
        "id": "sg:person.011007751054.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011007751054.33"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1158/1055-9965.epi-13-0625", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009146869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1055-9965.epi-13-0625", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009146869"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djp440", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015452363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1611310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016743702"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2016.03.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023458497"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1208/aapsj080110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028383494", 
          "https://doi.org/10.1208/aapsj080110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.6925", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029954603"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-016-3124-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030189858", 
          "https://doi.org/10.1007/s00280-016-3124-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-016-3124-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030189858", 
          "https://doi.org/10.1007/s00280-016-3124-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70240-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045417978"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aog.0000000000000917", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050370209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/aog.0000000000000917", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050370209"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.55.0459", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052094648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0033-0620(01)00027-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054604461"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1615/critreveukaryotgeneexpr.2013006875", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068131302"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/157488610789869148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069214857"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-017-3455-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092246117", 
          "https://doi.org/10.1007/s00280-017-3455-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctrv.2017.11.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099601480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-017-3512-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100290524", 
          "https://doi.org/10.1007/s00280-017-3512-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-017-3512-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100290524", 
          "https://doi.org/10.1007/s00280-017-3512-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-017-3512-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100290524", 
          "https://doi.org/10.1007/s00280-017-3512-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.25008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104125724"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "PURPOSE: Anticancer drugs may cause cardiovascular toxicities, including QT interval prolongation. Niraparib, a potent and selective once-daily oral poly (ADP-ribose) polymerase inhibitor, is approved as a maintenance therapy in platinum-sensitive recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer (EOC). Here, we present the effects of niraparib on cardiac repolarization, and the correlation between changes in baseline QT interval corrected by Fridericia's formula (\u0394QTcF) and niraparib plasma concentrations.\nMETHODS: Patients with EOC from the NOVA study (subset of n\u2009=\u200915), the food effect NOVA substudy (n\u2009=\u200917), and a QTc substudy (n\u2009=\u200926) underwent intensive electrocardiographic (ECG) monitoring that included triplicate ECG testing on Day 1 at baseline (predose) and at 1, 1.5, 2, 3, 4, 6, and 8\u00a0h postdose concurrent with time-matched blood sampling for determination of niraparib plasma concentrations. All patients received once-daily 300-mg niraparib until disease progression or toxicity.\nRESULTS: Across the 3 substudies, the upper limit of the two-sided 90% confidence interval (CI) of \u0394QTcF was \u2264\u200910\u00a0ms at every postdose timepoint, with a maximum upper limit of 4.3\u00a0ms, which indicates no clinically meaningful effect on QTc prolongation. No statistically significant relationship between \u0394QTcF and niraparib plasma concentration was observed (estimated slope: 0.0049; 95% CI: -\u20090.0020, 0.0117; P\u2009=\u20090.164). There were no clinically relevant changes in other ECG parameters that could be attributable to niraparib.\nCONCLUSION: Niraparib administration at the recommended daily dose of 300\u00a0mg for EOC is not associated with clinically relevant alteration of ECGs, including QTc prolongation.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-019-03774-w", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "4", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "83"
      }
    ], 
    "name": "Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer", 
    "pagination": "717-726", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "158aaeff9f33159425e84360cb63952f983d4a5d611667bf918fc18301e1bb9a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30680521"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-019-03774-w"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111636836"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-019-03774-w", 
      "https://app.dimensions.ai/details/publication/pub.1111636836"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000354_0000000354/records_11710_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00280-019-03774-w"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03774-w'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03774-w'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03774-w'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-019-03774-w'


 

This table displays all metadata directly associated to this object as RDF triples.

181 TRIPLES      21 PREDICATES      46 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-019-03774-w schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author Nb24be9f90f67423f991afc1fbbe1ebab
4 schema:citation sg:pub.10.1007/s00280-016-3124-5
5 sg:pub.10.1007/s00280-017-3455-x
6 sg:pub.10.1007/s00280-017-3512-5
7 sg:pub.10.1208/aapsj080110
8 https://doi.org/10.1016/j.ctrv.2017.11.009
9 https://doi.org/10.1016/j.ejca.2016.03.008
10 https://doi.org/10.1016/s0033-0620(01)00027-5
11 https://doi.org/10.1016/s1470-2045(13)70240-7
12 https://doi.org/10.1056/nejmoa1611310
13 https://doi.org/10.1093/jnci/djp440
14 https://doi.org/10.1097/aog.0000000000000917
15 https://doi.org/10.1158/1055-9965.epi-13-0625
16 https://doi.org/10.1200/jco.2006.09.6925
17 https://doi.org/10.1200/jco.2013.55.0459
18 https://doi.org/10.1615/critreveukaryotgeneexpr.2013006875
19 https://doi.org/10.18632/oncotarget.25008
20 https://doi.org/10.2174/157488610789869148
21 schema:datePublished 2019-04
22 schema:datePublishedReg 2019-04-01
23 schema:description PURPOSE: Anticancer drugs may cause cardiovascular toxicities, including QT interval prolongation. Niraparib, a potent and selective once-daily oral poly (ADP-ribose) polymerase inhibitor, is approved as a maintenance therapy in platinum-sensitive recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer (EOC). Here, we present the effects of niraparib on cardiac repolarization, and the correlation between changes in baseline QT interval corrected by Fridericia's formula (ΔQTcF) and niraparib plasma concentrations. METHODS: Patients with EOC from the NOVA study (subset of n = 15), the food effect NOVA substudy (n = 17), and a QTc substudy (n = 26) underwent intensive electrocardiographic (ECG) monitoring that included triplicate ECG testing on Day 1 at baseline (predose) and at 1, 1.5, 2, 3, 4, 6, and 8 h postdose concurrent with time-matched blood sampling for determination of niraparib plasma concentrations. All patients received once-daily 300-mg niraparib until disease progression or toxicity. RESULTS: Across the 3 substudies, the upper limit of the two-sided 90% confidence interval (CI) of ΔQTcF was ≤ 10 ms at every postdose timepoint, with a maximum upper limit of 4.3 ms, which indicates no clinically meaningful effect on QTc prolongation. No statistically significant relationship between ΔQTcF and niraparib plasma concentration was observed (estimated slope: 0.0049; 95% CI: - 0.0020, 0.0117; P = 0.164). There were no clinically relevant changes in other ECG parameters that could be attributable to niraparib. CONCLUSION: Niraparib administration at the recommended daily dose of 300 mg for EOC is not associated with clinically relevant alteration of ECGs, including QTc prolongation.
24 schema:genre research_article
25 schema:inLanguage en
26 schema:isAccessibleForFree false
27 schema:isPartOf Nb13e477472bc4c49aa3d1f9402b25489
28 Nba161e930c7342a281d4aa59490610c2
29 sg:journal.1088364
30 schema:name Effect of niraparib on cardiac repolarization in patients with platinum-sensitive, recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer
31 schema:pagination 717-726
32 schema:productId N0bac7dbb1a6f4ec88ecc8049571621d1
33 N1dc2e625fcc44a76b045b70fdef8f553
34 N3b9b48f4314b4514abb9e12c32e8922f
35 N4fd5df236763499cb496d1a477079f23
36 Nd5a157db101e49f481ee9f63883fc50d
37 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111636836
38 https://doi.org/10.1007/s00280-019-03774-w
39 schema:sdDatePublished 2019-04-11T11:19
40 schema:sdLicense https://scigraph.springernature.com/explorer/license/
41 schema:sdPublisher N37d5e1f1c8f24b0c835cbaeac9960bf5
42 schema:url https://link.springer.com/10.1007%2Fs00280-019-03774-w
43 sgo:license sg:explorer/license/
44 sgo:sdDataset articles
45 rdf:type schema:ScholarlyArticle
46 N0bac7dbb1a6f4ec88ecc8049571621d1 schema:name nlm_unique_id
47 schema:value 7806519
48 rdf:type schema:PropertyValue
49 N1dc2e625fcc44a76b045b70fdef8f553 schema:name doi
50 schema:value 10.1007/s00280-019-03774-w
51 rdf:type schema:PropertyValue
52 N1fb2429e224340ca94b8ec2f22850207 schema:name BioTel Research, Rockville, MD, USA
53 rdf:type schema:Organization
54 N2a172a46b3dc40459f2986b152d2135c rdf:first sg:person.013072753512.00
55 rdf:rest N7638bda3dafa4a3fbdce942501804e84
56 N37d5e1f1c8f24b0c835cbaeac9960bf5 schema:name Springer Nature - SN SciGraph project
57 rdf:type schema:Organization
58 N3b9b48f4314b4514abb9e12c32e8922f schema:name pubmed_id
59 schema:value 30680521
60 rdf:type schema:PropertyValue
61 N4fd5df236763499cb496d1a477079f23 schema:name readcube_id
62 schema:value 158aaeff9f33159425e84360cb63952f983d4a5d611667bf918fc18301e1bb9a
63 rdf:type schema:PropertyValue
64 N7638bda3dafa4a3fbdce942501804e84 rdf:first sg:person.01153251200.71
65 rdf:rest Nd9384ab4e4604d76a94254358e699d36
66 N9d9046d01e264ed29f7c6985b43a55f0 schema:affiliation N1fb2429e224340ca94b8ec2f22850207
67 schema:familyName Callahan
68 schema:givenName Timothy
69 rdf:type schema:Person
70 Nad5e158a169b4cabb7bd710fb522400d rdf:first N9d9046d01e264ed29f7c6985b43a55f0
71 rdf:rest Nd7e21ffd9b174675a183dd9a7b7dd84d
72 Nb13e477472bc4c49aa3d1f9402b25489 schema:volumeNumber 83
73 rdf:type schema:PublicationVolume
74 Nb24be9f90f67423f991afc1fbbe1ebab rdf:first sg:person.014355765517.07
75 rdf:rest N2a172a46b3dc40459f2986b152d2135c
76 Nba161e930c7342a281d4aa59490610c2 schema:issueNumber 4
77 rdf:type schema:PublicationIssue
78 Ncccca9d351a6479e85b06a0d8262bfb6 rdf:first sg:person.011007751054.33
79 rdf:rest rdf:nil
80 Nd5a157db101e49f481ee9f63883fc50d schema:name dimensions_id
81 schema:value pub.1111636836
82 rdf:type schema:PropertyValue
83 Nd7e21ffd9b174675a183dd9a7b7dd84d rdf:first sg:person.013451310020.45
84 rdf:rest Ncccca9d351a6479e85b06a0d8262bfb6
85 Nd9384ab4e4604d76a94254358e699d36 rdf:first sg:person.01063520446.11
86 rdf:rest Nad5e158a169b4cabb7bd710fb522400d
87 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
88 schema:name Medical and Health Sciences
89 rdf:type schema:DefinedTerm
90 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
91 schema:name Cardiorespiratory Medicine and Haematology
92 rdf:type schema:DefinedTerm
93 sg:journal.1088364 schema:issn 0344-5704
94 1432-0843
95 schema:name Cancer Chemotherapy and Pharmacology
96 rdf:type schema:Periodical
97 sg:person.01063520446.11 schema:affiliation https://www.grid.ac/institutes/grid.488785.e
98 schema:familyName Patel
99 schema:givenName Manish R.
100 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01063520446.11
101 rdf:type schema:Person
102 sg:person.011007751054.33 schema:affiliation https://www.grid.ac/institutes/grid.476732.3
103 schema:familyName Zhang
104 schema:givenName Zhi-Yi
105 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011007751054.33
106 rdf:type schema:Person
107 sg:person.01153251200.71 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
108 schema:familyName Secord
109 schema:givenName Angeles Alvarez
110 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153251200.71
111 rdf:type schema:Person
112 sg:person.013072753512.00 schema:affiliation https://www.grid.ac/institutes/grid.17866.3e
113 schema:familyName Chan
114 schema:givenName John K.
115 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013072753512.00
116 rdf:type schema:Person
117 sg:person.013451310020.45 schema:affiliation https://www.grid.ac/institutes/grid.476732.3
118 schema:familyName Guo
119 schema:givenName Wei
120 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013451310020.45
121 rdf:type schema:Person
122 sg:person.014355765517.07 schema:affiliation https://www.grid.ac/institutes/grid.419513.b
123 schema:familyName Moore
124 schema:givenName Kathleen
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014355765517.07
126 rdf:type schema:Person
127 sg:pub.10.1007/s00280-016-3124-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030189858
128 https://doi.org/10.1007/s00280-016-3124-5
129 rdf:type schema:CreativeWork
130 sg:pub.10.1007/s00280-017-3455-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1092246117
131 https://doi.org/10.1007/s00280-017-3455-x
132 rdf:type schema:CreativeWork
133 sg:pub.10.1007/s00280-017-3512-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100290524
134 https://doi.org/10.1007/s00280-017-3512-5
135 rdf:type schema:CreativeWork
136 sg:pub.10.1208/aapsj080110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028383494
137 https://doi.org/10.1208/aapsj080110
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1016/j.ctrv.2017.11.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099601480
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1016/j.ejca.2016.03.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023458497
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1016/s0033-0620(01)00027-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054604461
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1016/s1470-2045(13)70240-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045417978
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1056/nejmoa1611310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016743702
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1093/jnci/djp440 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015452363
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1097/aog.0000000000000917 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050370209
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1158/1055-9965.epi-13-0625 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009146869
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1200/jco.2006.09.6925 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029954603
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1200/jco.2013.55.0459 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052094648
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1615/critreveukaryotgeneexpr.2013006875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068131302
160 rdf:type schema:CreativeWork
161 https://doi.org/10.18632/oncotarget.25008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104125724
162 rdf:type schema:CreativeWork
163 https://doi.org/10.2174/157488610789869148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069214857
164 rdf:type schema:CreativeWork
165 https://www.grid.ac/institutes/grid.17866.3e schema:alternateName California Pacific Medical Center
166 schema:name Palo Alto Medical Foundation, California Pacific Medical Center, Sutter Health Sutter West Bay, San Francisco, CA, USA
167 rdf:type schema:Organization
168 https://www.grid.ac/institutes/grid.26009.3d schema:alternateName Duke University
169 schema:name Duke Cancer Institute, Durham, NC, USA
170 rdf:type schema:Organization
171 https://www.grid.ac/institutes/grid.419513.b schema:alternateName Sarah Cannon
172 schema:name Sarah Cannon Research Institute, Nashville, TN, USA
173 Stephenson Cancer Center, University of Oklahoma HSC, 800 NE 10th St #2500, 73104, Oklahoma City, OK, USA
174 rdf:type schema:Organization
175 https://www.grid.ac/institutes/grid.476732.3 schema:alternateName Tesaro (United States)
176 schema:name TESARO, Inc, Waltham, MA, USA
177 rdf:type schema:Organization
178 https://www.grid.ac/institutes/grid.488785.e schema:alternateName Florida Cancer Specialists & Research Institute
179 schema:name Florida Cancer Specialists and Research Institute, Sarasota, FL, USA
180 Sarah Cannon Research Institute, Nashville, TN, USA
181 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...